GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Titan Medical Inc (TSX:TMD) » Definitions » Cyclically Adjusted Price-to-FCF

Titan Medical (TSX:TMD) Cyclically Adjusted Price-to-FCF : (As of May. 02, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Titan Medical Cyclically Adjusted Price-to-FCF?

Shiller PE for Stocks: The True Measure of Stock Valuation


Titan Medical Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Titan Medical's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Titan Medical Cyclically Adjusted Price-to-FCF Chart

Titan Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Titan Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Titan Medical's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Titan Medical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Titan Medical's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Titan Medical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Titan Medical's Cyclically Adjusted Price-to-FCF falls into.



Titan Medical Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Titan Medical's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Titan Medical's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.008/125.4675*125.4675
=-0.008

Current CPI (Dec. 2023) = 125.4675.

Titan Medical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 -0.895 98.604 -1.139
201406 -0.619 99.473 -0.781
201409 -1.500 99.394 -1.893
201412 -1.719 98.367 -2.193
201503 -2.430 99.789 -3.055
201506 -2.715 100.500 -3.389
201509 -3.818 100.421 -4.770
201512 -3.953 99.947 -4.962
201603 -5.784 101.054 -7.181
201606 -2.105 102.002 -2.589
201609 -1.728 101.765 -2.130
201612 -0.937 101.449 -1.159
201703 -0.992 102.634 -1.213
201706 -0.804 103.029 -0.979
201709 -0.840 103.345 -1.020
201712 -0.631 103.345 -0.766
201803 -0.580 105.004 -0.693
201806 -0.659 105.557 -0.783
201809 -0.799 105.636 -0.949
201812 -1.113 105.399 -1.325
201903 -1.109 106.979 -1.301
201906 -0.567 107.690 -0.661
201909 -0.550 107.611 -0.641
201912 -0.504 107.769 -0.587
202003 -0.080 107.927 -0.093
202006 0.137 108.401 0.159
202009 -0.078 108.164 -0.090
202012 -0.005 108.559 -0.006
202103 -0.174 110.298 -0.198
202106 -0.011 111.720 -0.012
202109 -0.120 112.905 -0.133
202112 -0.143 113.774 -0.158
202203 -0.024 117.646 -0.026
202206 -0.113 120.806 -0.117
202209 -0.101 120.648 -0.105
202212 -0.100 120.964 -0.104
202303 -0.024 122.702 -0.025
202306 0.087 124.203 0.088
202309 -0.019 125.230 -0.019
202312 -0.008 125.468 -0.008

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Titan Medical  (TSX:TMD) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Titan Medical Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Titan Medical's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Titan Medical (TSX:TMD) Business Description

Traded in Other Exchanges
Address
76 Berkeley Street, Toronto, ON, CAN, M5A 2W7
Titan Medical Inc is in the research and development stage and is focused on the continued design and development of robotic-assisted surgical technologies for application in minimally invasive surgery including the development of the Enos robotic single-access surgical system.

Titan Medical (TSX:TMD) Headlines

No Headlines